Your browser doesn't support javascript.
loading
Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer.
Remmers, Sebastiaan; Bangma, Chris H; Godtman, Rebecka A; Carlsson, Sigrid V; Auvinen, Anssi; Tammela, Teuvo L J; Denis, Louis J; Nelen, Vera; Villers, Arnauld; Rebillard, Xavier; Kwiatkowski, Maciej; Recker, Franz; Wyler, Stephen; Zappa, Marco; Puliti, Donella; Gorini, Giuseppe; Paez, Alvaro; Lujan, Marcos; Nieboer, Daan; Schröder, Fritz H; Roobol, Monique J.
Afiliação
  • Remmers S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands. Electronic address: s.remmers@erasmusmc.nl.
  • Bangma CH; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Godtman RA; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden.
  • Carlsson SV; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden; Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Auvinen A; School of Health Sciences, University of Tampere, Tampere, Finland.
  • Tammela TLJ; Department of Urology, Tampere University and Tampere University Hospital, Tampere, Finland.
  • Denis LJ; Department of Urology, Meeting Centre Antwerp, Antwerp, Belgium.
  • Nelen V; Provincial Institute for Hygiene, Antwerp, Belgium.
  • Villers A; Department of Urology, Université Lille Nord de France, Lille, France.
  • Rebillard X; Department of Urology, Clinique Beau Soleil, Montpellier, France.
  • Kwiatkowski M; Department of Urology, Kantonsspital Aarau, Aarau, Switzerland; Medical Faculty, University of Basel, Basel, Switzerland; Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany.
  • Recker F; PolyClinic St. Moritz/Scuol, Switzerland.
  • Wyler S; Department of Urology, Kantonsspital Aarau, Aarau, Switzerland; Medical Faculty, University of Basel, Basel, Switzerland.
  • Zappa M; Oncologic Network, Prevention and Research Institute (ISPRO), Florence, Italy.
  • Puliti D; Oncologic Network, Prevention and Research Institute (ISPRO), Florence, Italy.
  • Gorini G; Oncologic Network, Prevention and Research Institute (ISPRO), Florence, Italy.
  • Paez A; Department of Urology, Hospital Universitario de Fuenlabrada, Madrid, Spain.
  • Lujan M; Department of Urology, Hospital Infanta Cristina, Madrid, Spain.
  • Nieboer D; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Schröder FH; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Eur Urol ; 84(5): 503-509, 2023 11.
Article em En | MEDLINE | ID: mdl-37088597
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article